Arbutus Biopharma Announces Issuance of a New Key U.S. Patent Related to AB-729
WARMINSTER, Pa., Aug. 30, 2022 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target... | August 30, 2022